What was the main takeaway from the Dyno Nobel (ASX:DNL) 1H26 results?

Dyno Nobel reaffirmed its full-year earnings guidance following a strong first-half performance where underlying profit surged. The company successfully completed the legal separation of its fertiliser business, including the divestment of Phosphate Hill, to focus entirely on its explosives operations.

Why did Dyno Nobel (ASX:DNL) report a 83% jump in underlying NPAT?

The 83% increase in Net Profit After Tax (NPAT) ex IMIs, reaching $161 million, was primarily driven by robust operational performance in the DNAP and DNA explosives divisions. By stripping away one-off costs associated with exiting the fertiliser sector, the underlying figures reflect the improved margins and efficiency of the core explosives business.

How did the fertiliser business separation impact Dyno Nobel’s statutory profit?

While underlying figures were strong, statutory net profit after tax was a much lower $20 million due to $141 million in one-off charges. These "individually material items" (IMIs) related to impairment and exit costs from the sale of the Phosphate Hill site and the broader fertiliser transition.

What is the dividend and buyback outlook for Dyno Nobel (ASX:DNL) shareholders?

Dyno Nobel declared an unfranked interim dividend of 4.6 cents per share, which represents a 50% payout ratio of its earnings. Furthermore, the company has already completed $558 million of its massive $900 million on-market share buyback program.

What are the main "bull" points for Dyno Nobel (ASX:DNL) after this news?

The "bull case" rests on Dyno Nobel becoming a more efficient, high-margin explosives specialist without the earnings volatility of the fertiliser market. Strong double-digit growth in EBIT and NPAT suggests the "pureplay" strategy is working, and the substantial share buyback provides a floor for the stock price by reducing share supply.

What are the key risks or "bear" points for investors to watch?

A notable risk is the decline in safety performance, with the Total Recordable Injury Frequency Rate (TRIFR) rising from 0.92 to 1.22. In the industrial and mining services sector, poor safety metrics can lead to regulatory scrutiny or operational shutdowns that impact long-term contracts.

How does the current Dyno Nobel (ASX:DNL) strategy differ from previous years?

Under CEO Mauro Neves, Dyno Nobel has moved away from being a diversified chemicals and fertilisers company to a focused explosives leader. The "beginning of a new era" refers to the completion of the fertiliser divestment, allowing the company to dedicate all capital and management focus to its "privileged assets" in explosives.

Dyno Nobel reaffirms guidance as explosives earnings soar

Written by Jon CuthbertPublished May. 10 2026Last Updated May. 10 2026

Dyno Nobel (ASX:DNL) has reaffirmed its full-year earnings guidance following its first-half performance for 2026.

The company reported a surge in underlying profitability, underpinned by the legal separation of its fertiliser business, including the divestment of the Phosphate Hill site.

The explosives specialist delivered an EBIT ex IMIs of $243 million, representing a 39% increase over the prior corresponding period.

The growth was largely driven by strong operational performance across its DNAP and DNA divisions.

Statutory net profit after tax rose to $20 million, up from $7 million in H1 FY25, despite being tempered by $141 million in individually material items related to impairment and exit costs from the fertiliser transition.

Stripping away these one-off items, the net profit after tax reached $161 million, an impressive 83% jump year-on-year.

CEO Mauro Neves characterised the period as the "beginning of a new era", noting that the company’s transformation programme is delivering resilient results.

Shareholders are set to benefit from an unfranked interim dividend of 4.6 cents per share, reflecting a 50% payout ratio.

Dyno Nobel has completed $558 million of its ongoing $900 million on-market share buyback.

While financial metrics soared, the company noted a rise in its total recordable injury frequency rate to 1.22, up from 0.92.